Sarah J. Schweber

Oncology

650 Commack Rd
Commack, NY 11725

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 02, 2018

Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.

Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.

Journal: The oncologist

Published: July 07, 2016

Therapies for triple negative breast cancer.

Therapies for triple negative breast cancer.

Journal: Expert opinion on pharmacotherapy

Published: April 18, 2015

Showing 1-3 of 3

Last Updated: 09/26/2026